Wegovy 0.5 mg semaglutide injection

Wegovy is a prescription medication containing the active ingredient semaglutide, specifically designed for chronic weight management. It is delivered via the FlexTouch pre-filled pen system. The brand is a flagship product of the Danish pharmaceutical giant Novo Nordisk, which has been a leader in diabetes and metabolic healthcare for over a century.

While the brand and the primary research and development originate from Denmark, Novo Nordisk operates a vast global manufacturing network. The active ingredient and the final assembly of the injection pens are often conducted at their large-scale facilities in Kalundborg and Bagsværd, Denmark, but to meet global demand, production also occurs in France and the United States. Ownership remains entirely with Novo Nordisk, which is headquarters in Denmark and is majority-controlled by the Novo Nordisk Foundation.